Skip to content

Clinical trials

Multiple Myeloma trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Lithuania Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20111
20121
20131
20151
20172
20181
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting3
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Amgen2
Janssen-Cilag International NV2
Henrik Gregersen1
Janssen Pharmaceutica N.V., Belgium1
JaxBio Ltd1
Lithuanian University of Health Sciences1
Oncopeptides AB1
Raija Silvennoinen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma13
Recurrence3
Bone Marrow Neoplasms2
Hematologic Neoplasms2
Neoplasms2
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Neoplasms1
Disease Progression1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.